PREVENT Risk Calculator Maintains Accuracy in Real-World EHR Settings Despite Missing Data The American Heart Association’s PREVENT™ cardiovascular risk calculator demonstrates reliable performance in real-world electronic health record (EHR) environments, even when faced with incomplete patient data, according to recent research. This finding supports the tool’s utility for clinicians seeking to assess cardiovascular disease risk in routine practice settings. Understanding the PREVENT™ Risk Calculator The PREVENT™ (Predicting Risk of Cardiovascular Disease EVENTs) calculator, developed by the American Heart Association, represents an updated approach to cardiovascular risk assessment. Unlike older models that primarily focused on atherosclerotic cardiovascular disease (ASCVD), PREVENT™ provides comprehensive risk estimates for multiple cardiovascular outcomes including total CVD, ASCVD, heart failure, coronary heart disease, and stroke. The calculator incorporates contemporary factors such as kidney function, measured via estimated glomerular filtration rate (eGFR), and albuminuria, alongside traditional risk factors like age, blood pressure, cholesterol levels, diabetes status, and smoking status. Body mass index (BMI) is also utilized in the risk equations. Validation in Real-World EHR Data Research evaluating the PREVENT™ calculator’s performance in actual clinical settings has shown that it maintains accuracy despite common challenges in EHR data completeness. Studies indicate that the risk prediction models underlying PREVENT™ remain robust when key variables are missing, a frequent occurrence in busy clinical practices where not all laboratory values or measurements are routinely recorded for every patient encounter. This resilience to missing data is particularly valuable because it allows clinicians to obtain meaningful risk estimates without requiring perfect data completeness. The calculator’s design appears to accommodate the realities of primary care and cardiology workflows where clinicians must often develop risk assessment decisions based on available information. Clinical Implementation and Accessibility The PREVENT™ calculator is accessible through multiple platforms to support widespread adoption. The American Heart Association provides an online version via their professional website, while integration into electronic health record systems is facilitated through partnerships with health technology companies. For example, Elation Health has incorporated the PREVENT™ equations directly into their EHR platform, enabling seamless risk calculation during patient chart reviews without requiring clinicians to navigate to external tools. Such EHR integration addresses a significant barrier to preventive cardiology implementation by embedding risk assessment within existing clinical workflows. When risk calculators are readily available at the point of care, clinicians are more likely to use them consistently for patient risk stratification and preventive care planning. Advantages Over Previous Risk Models Compared to its predecessor, the Pooled Cohort Equations (PCE) introduced in 2013, PREVENT™ offers several advancements. The newer model was developed using more recent and diverse cohort data, better representing the contemporary U.S. Population. By including heart failure risk—a major contributor to cardiovascular morbidity and mortality—PREVENT™ provides a more holistic view of cardiovascular health risks than models focused solely on atherosclerotic events. PREVENT™ removes race as a biological variable, addressing longstanding concerns about equity in cardiovascular risk prediction. Instead, the model incorporates social determinants of health through neighborhood-level deprivation indices when available, although the core calculator functions without this data. Practical Application in Patient Care In clinical practice, the PREVENT™ calculator helps guide shared decision-making between patients and clinicians regarding preventive interventions. Risk estimates can inform discussions about lifestyle modifications, statin therapy, blood pressure management, and other preventive strategies tailored to an individual’s predicted cardiovascular risk over specific time horizons (typically 10-year and 30-year estimates). The calculator’s ability to provide subtype-specific risk estimates (e.g., distinguishing between heart failure and atherosclerotic risk) allows for more precise preventive planning. For instance, a patient with elevated heart failure risk but lower ASCVD risk might benefit from different interventions than someone with the inverse pattern. Future Directions and Ongoing Evaluation As with any clinical risk tool, ongoing validation in diverse populations and settings remains important. Researchers continue to monitor PREVENT™’s performance across different demographic groups, geographic regions, and healthcare systems to ensure equitable and accurate risk prediction. The calculator’s developers emphasize that it should be used as one component of a comprehensive cardiovascular risk assessment, complemented by clinical judgment and patient-specific factors not captured in any risk equation. The PREVENT™ calculator represents a significant evolution in cardiovascular risk assessment technology, offering improved accuracy, inclusivity, and practical utility for modern clinical practice. Its demonstrated resilience to missing data in EHR settings enhances its value as a tool for preventive cardiology in real-world healthcare environments.
26